Valuation: Lonza Group AG

Market Cap 39.66B 49.18B 42.98B 36.55B 68.9B 4,736B 70.43B 474B 186B 2,319B 185B 181B 7,985B P/E 2026 *
34.3x
P/E 2027 * 28.2x
Enterprise Value 42.87B 53.16B 46.46B 39.52B 74.48B 5,120B 76.14B 512B 202B 2,507B 200B 195B 8,632B EV / Sales 2026 *
6.01x
EV / Sales 2027 * 5.33x
Free-Float
99.36%
Yield 2026 *
0.96%
Yield 2027 * 1.1%
1 day-1.29%
1 week-3.11%
Current month+4.03%
1 month+15.50%
3 months+4.49%
6 months+1.54%
Current year+5.58%
1 week 565.2
Extreme 565.2
588.8
1 month 497
Extreme 497
591
Current year 454.6
Extreme 454.6
591
1 year 454.6
Extreme 454.6
594.8
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 54 2021-11-30
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Director/Board Member 67 2016-04-25
Director/Board Member 66 2018-05-03
Director/Board Member 60 2022-05-04
Date Insider Type Main position Quantity % Market Cap.
5/8/26 Buy 618 0.0009%
5/8/26 Buy 460 0.0007%
3/11/26 Sell 179 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.29%-3.11%-0.35%+3.09% 49.18B
+3.90%-0.39%+386.06%+593.85% 39.58B
-1.70%+4.46%+5.93%+60.25% 34.69B
-2.01%-0.76%+28.41%-8.01% 34.42B
+0.06%+0.34%+2.38%+34.38% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+72.42%+115.55% 15.36B
+1.12%+1.91%+14.54%+19.16% 14.05B
0.00%+1.36%+18.43%-30.79% 13.02B
-0.08%-3.01%+1,282.83%+635.80% 11.76B
Average +0.04%-0.28%+201.18%+158.14% 25.54B
Weighted average by Cap. -0.05%-0.31%+138.60%+148.51%

Financials

2026 *2027 *
Net sales 7.14B 8.85B 7.74B 6.58B 12.4B 852B 12.68B 85.32B 33.56B 417B 33.24B 32.51B 1,437B 7.99B 9.91B 8.66B 7.37B 13.88B 954B 14.19B 95.51B 37.57B 467B 37.21B 36.4B 1,609B
Net income 1.16B 1.44B 1.26B 1.07B 2.02B 139B 2.06B 13.87B 5.45B 67.85B 5.4B 5.28B 234B 1.4B 1.74B 1.52B 1.29B 2.44B 167B 2.49B 16.75B 6.59B 81.98B 6.53B 6.38B 282B
Net Debt 3.21B 3.99B 3.48B 2.96B 5.59B 384B 5.71B 38.43B 15.11B 188B 14.97B 14.64B 647B 2.92B 3.62B 3.16B 2.69B 5.07B 348B 5.18B 34.86B 13.71B 171B 13.58B 13.29B 587B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,000
Date Price Change Volume
26-07-17 CHF 567.80 -1.29% 138,483
26-07-16 CHF 575.20 -1.07% 154,646
26-07-15 CHF 581.40 -0.17% 142,597
26-07-14 CHF 582.40 -1.05% 100,085
26-07-13 CHF 588.60 +0.44% 142,361
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
567.80CHF
Average target price
669.22CHF
Spread / Average Target
+17.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LONN Stock